IndraLab

Statements


OTUD5 inhibits TAK1-MAPK. 1 / 1
| 1

reach
"In addition, OTUD5 inhibited the activation of the TAK1-MAPK pathway in HG/PA-treated podocytes but failed when its deubiquitinating activity was canceled in the C224S mutant (Fig. 5j)."